171 related articles for article (PubMed ID: 22809091)
41. Comparison of ocular hypotensive actions of fixed combinations of brimonidine/timolol and dorzolamide/timolol.
García-Feijoó J; Sáenz-Francés F; Martínez-de-la-Casa JM; Méndez-Hernández C; Fernández-Vidal A; Calvo-González C; García-Sánchez J
Curr Med Res Opin; 2010 Jul; 26(7):1599-606. PubMed ID: 20429818
[TBL] [Abstract][Full Text] [Related]
42. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
43. The short-term effect of adding brimonidine 0.2% to timolol treatment in patients with open-angle glaucoma.
Yüksel N; Altintaş O; Karabaş L; Alp B; Cağlar Y
Ophthalmologica; 1999; 213(4):228-33. PubMed ID: 10420106
[TBL] [Abstract][Full Text] [Related]
44. Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
Konstas AG; Katsimpris IE; Kaltsos K; Georgiadou I; Kordelou A; Nelson LA; Stewart WC
Eye (Lond); 2008 Nov; 22(11):1391-7. PubMed ID: 17571086
[TBL] [Abstract][Full Text] [Related]
45. [Efficacy of topic ocular hipotensive agents after posterior capsulotomy].
Minello AA; Prata Junior JA; Mello PA
Arq Bras Oftalmol; 2008; 71(5):706-10. PubMed ID: 19039468
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma.
Park SW; Kim JM; Lee JW; Maglambayan J; Simonyi S; Park KH
Jpn J Ophthalmol; 2021 Mar; 65(2):295-305. PubMed ID: 33591471
[TBL] [Abstract][Full Text] [Related]
47. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
48. Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
Spaeth GL; Bernstein P; Caprioli J; Schiffman RM
Am J Ophthalmol; 2011 Jan; 151(1):93-99.e4. PubMed ID: 21111399
[TBL] [Abstract][Full Text] [Related]
49. [Effect of posterior neodymium:YAG capsulotomy. Safety evaluation of macular foveal thickness, intraocular pressure and endothelial cell loss in pseudophakic patients with posterior capsule opacification].
Ruiz-Casas D; Barrancos C; Alio JL; Ruiz-Guerrero M; Muñoz-Negrete FJ
Arch Soc Esp Oftalmol; 2013 Nov; 88(11):415-22. PubMed ID: 24157319
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
[TBL] [Abstract][Full Text] [Related]
51. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
[TBL] [Abstract][Full Text] [Related]
52. Refraction, intraocular pressure and anterior chamber depth changes after Nd:YAG laser treatment for posterior capsular opacification in pseudophakic eyes.
Ozkurt YB; Sengör T; Evciman T; Haboğlu M
Clin Exp Optom; 2009 Sep; 92(5):412-5. PubMed ID: 19549226
[TBL] [Abstract][Full Text] [Related]
53. The effects of Nd:YAG laser posterior capsulotomy on macular thickness, intraocular pressure, and visual acuity.
Ari S; Cingü AK; Sahin A; Çinar Y; Çaça I
Ophthalmic Surg Lasers Imaging; 2012; 43(5):395-400. PubMed ID: 22785102
[TBL] [Abstract][Full Text] [Related]
54. The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.
Chen MJ; Chou JC; Hsu WM; Liu JH
J Chin Med Assoc; 2003 May; 66(5):276-81. PubMed ID: 12908569
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
Kim JM; Kim TW; Kim CY; Kim HK; Park KH
Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
[TBL] [Abstract][Full Text] [Related]
57. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
[TBL] [Abstract][Full Text] [Related]
58. The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty.
Ma YR; Lee BH; Yang KJ; Park YG
Korean J Ophthalmol; 1999 Dec; 13(2):78-84. PubMed ID: 10761402
[TBL] [Abstract][Full Text] [Related]
59. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
Sesar A; Petric I; Sesar I; Lacmnovic-Loncar V; Jurisić D; Tomić Z; Mandić Z
Acta Med Croatica; 2006; 60(2):109-12. PubMed ID: 16848199
[TBL] [Abstract][Full Text] [Related]
60. [Prevention of early postoperative increase in intraocular pressure after phacoemulsification. Comparison of different antiglaucoma drugs].
Schwenn O; Xia N; Krummenauer F; Dick HB
Ophthalmologe; 2001 Oct; 98(10):934-43. PubMed ID: 11699314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
